tiprankstipranks
Editas Medicine Inc (EDIT)
NASDAQ:EDIT
US Market

Editas Medicine (EDIT) Technical Analysis

Compare
3,392 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
1Neutral
8Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
6Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Editas Medicine Inc’s (EDIT) Moving Averages Convergence Divergence (MACD) indicator is 0.14, suggesting Editas Medicine Inc is a Sell.
Editas Medicine Inc’s (EDIT) 20-Day exponential moving average is 1.52, while Editas Medicine Inc’s (EDIT) share price is $3.2, making it a Buy.
Editas Medicine Inc’s (EDIT) 50-Day exponential moving average is 1.64, while Editas Medicine Inc’s (EDIT) share price is $3.2, making it a Buy.

Editas Medicine (EDIT) Pivot Points

Feb 21, 2025, 08:28 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.16
1.29
1.51
1.64
1.86
1.99
2.21
Fibonacci
1.29
1.42
1.50
1.64
1.77
1.85
1.99
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Editas Medicine (EDIT) Moving Averages

Feb 21, 2025, 08:28 AM
Period
Simple
Exponential
MA5
1.75Buy
2.02Buy
MA10
1.50Buy
1.69Buy
MA20
1.43Buy
1.52Buy
MA50
1.44Buy
1.64Buy
MA100
2.21Buy
2.24Buy
MA200
3.51Sell
3.59Sell
Editas Medicine Inc’s (EDIT) 10-Day exponential moving average is 1.69, while Editas Medicine Inc’s (EDIT) share price is $3.2, making it a Buy.
Editas Medicine Inc’s (EDIT) 100-Day exponential moving average is 2.24, while Editas Medicine Inc’s (EDIT) share price is $3.2, making it a Buy.
Editas Medicine Inc’s (EDIT) stock price is $3.2 and Editas Medicine Inc’s (EDIT) 50-day simple moving average is 1.44, creating a Buy signal.
Editas Medicine Inc’s (EDIT) stock price is $3.2 and Editas Medicine Inc’s (EDIT) 100-day simple moving average is 2.21, creating a Buy signal.
Editas Medicine Inc’s (EDIT) stock price is $3.2 and Editas Medicine Inc’s (EDIT) 200-day simple moving average is 3.51, creating a Sell signal.

Editas Medicine (EDIT) Technical Indicators

Feb 21, 2025, 08:28 AM
Name
Value
Implied Action
RSI (14)
86.95
Sell
STOCH (9,6)
88.18
Sell
STOCHRSI (14)
88.18
Sell
MACD (12,26)
0.14
Sell
ADX (14)
21.49
Neutral
Williams %R
-4.54
Sell
CCI (14)
567.89
Sell
ATR (14)
0.24
-
Ultimate Oscillator
79.60
Buy
ROC
138.81
Buy
Editas Medicine Inc’s (EDIT) Relative Strength Index (RSI) is 86.95, creating a Sell signal.
Editas Medicine Inc’s (EDIT) Trend Strength Indicator (ADX) is 21.49, creating a Neutral signal.
Editas Medicine Inc’s (EDIT) Commodity Channel Index (CCI) is 567.89, creating a Sell signal.
Editas Medicine Inc’s (EDIT) Price Rate of Change (ROC) is 138.81, creating a Buy signal.

FAQ

Is EDIT a Buy, Hold, or Sell?
Based on EDIT’s technical indicators, EDIT is a Buy.
    What is EDIT’s RSI (14)?
    EDIT’s RSI (14) is 86.95, which suggests EDIT is a Sell.
      What is EDIT’s MACD?
      EDIT’s MACD is 0.14, which suggests EDIT is a Sell.
        What is EDIT’s 5-day moving average?
        EDIT’s 5-day moving average is 1.75, which suggests EDIT is a Buy.
          What is EDIT’s 20-day moving average?
          EDIT 20-day moving average is 1.43, which suggests EDIT is a Buy.
            What is EDIT’s 50-day moving average?
            EDIT’s 50-day moving average is 1.44, which suggests EDIT is a Buy.
              What is EDIT’s 200-day moving average?
              EDIT’s 200-day moving average is 3.51, which suggests EDIT is a Sell.
                What is EDIT’s Williams % R (14)?
                EDIT’s Williams % R (14) is -4.54, which suggests EDIT is a Sell.
                  What is EDIT’s CCI (14)?
                  EDIT’s CCI (14) is 567.89, which suggests EDIT is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis